Roswell Park Comprehensive Cancer Center Licenses Invivoscribe’s LymphoTrack Software for Plug and Play Pipeline Useadmin2021-09-02T16:53:40+00:00September 2nd, 2021|2021 Press Releases, Press Releases| Read More
Invivoscribe Announces Key Submission in the EU, Expanded Presence and Activity in Chinaadmin2021-07-22T17:27:56+00:00July 22nd, 2021|2021 Press Releases, Press Releases| Read More
Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencingadmin2021-04-27T17:17:21+00:00April 20th, 2021|2021 Publications, Publications| Read More
